SwedenKidney TransplantationTransplantsGraft RejectionGraft SurvivalImmunosuppressive AgentsHeart TransplantationTransplantation, HomologousTransplantationTissue DonorsLung TransplantationTissue and Organ ProcurementBone Marrow TransplantationTime FactorsRetrospective StudiesCyclosporineTacrolimusTreatment OutcomeLiving DonorsPostoperative ComplicationsWaiting ListsRisk FactorsImmunosuppressionHematopoietic Stem Cell TransplantationIncidenceRegistriesFetal Tissue TransplantationCytomegalovirus InfectionsMycophenolic AcidFollow-Up StudiesHistocompatibility TestingCadaverTransplantation ImmunologyKidney Failure, ChronicImmunocompromised HostLiver FailureGraft vs Host DiseaseCohort StudiesHeart-Lung TransplantationProspective StudiesScandinaviaBrain Tissue TransplantationTransplantation, AutologousEuropeSurvival RateBronchiolitis ObliteransTransplantation, HeterotopicSurvival AnalysisHistocompatibilityRecurrenceAge FactorsTransplantation ToleranceOpportunistic InfectionsCytomegalovirusTransplantation ConditioningBK VirusBiopsyRisk AssessmentHLA AntigensGanciclovirAntilymphocyte SerumIsoantibodiesPolyomavirus InfectionsKidneyLymphoproliferative DisordersEnd Stage Liver DiseaseAcute DiseaseTransplantation, IsogeneicHematologic NeoplasmsPrevalenceCase-Control StudiesIslets of Langerhans TransplantationCreatinineLiver DiseasesKidney DiseasesPrognosisMultivariate AnalysisProportional Hazards ModelsQuestionnairesDenmarkMycosesPostoperative PeriodSex FactorsCross-Sectional StudiesRiskPrimary Graft DysfunctionAntiviral AgentsUnited StatesNorwayInfant, NewbornAge DistributionWhole-Body IrradiationReoperationSirolimusLeukemiaInfectionFatal OutcomeStem Cell TransplantationCause of DeathPolymerase Chain Reaction